nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.09.2009 | Brief Report

Influence of tracheostomy on the incidence of central venous catheter-related bacteremia

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Although there are many studies on catheter-related infection, there are scarce data about the influence of tracheostomy in the incidence of central venous catheter-related bacteremia (CRB). In this cohort study, we found a higher incidence of CRB in patients with tracheostomy than without (11.25 vs. 1.43 per 1,000 catheter-days; odds ratio [OR] = 7.99; 95% confidence interval [CI] = 4.38–infinite; P < 0.001). Besides, we found a higher incidence of CRB in patients with tracheostomy using the jugular access compared to subclavian access (21.64 vs. 5.11 per 1,000 catheter-days; OR = 4.23; 95% CI = 1.44–infinite; P = 0.0097).

Collignon P, Soni N, Pearson I, Sorrell T, Woods P (1988) Sepsis associated with central vein catheters in critically ill patients. Intensive Care Med 14:227–231. doi:10.1007/BF00717995 PubMedCrossRef

Goetz AM, Wagener MM, Miller JM, Muder RR (1998) Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 19:842–845PubMedCrossRef

Deshpande KS, Hatem C, Ulrich HL, Currie BP, Aldrich TK, Bryan-Brown CW, Kvetan V (2005) The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 33:13–20. doi:10.1097/01.CCM.0000149838.47048.60 PubMedCrossRef

Lorente L, Villegas J, Martín MM, Jiménez A, Mora ML (2004) Catheter-related infection in critically ill patients. Intensive Care Med 30(8):1681–1684. doi:10.1007/s00134-004-2332-3 PubMedCrossRef

Lorente L, Henry C, Martín MM, Jiménez A, Mora ML (2005) Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care 9:R631–R635. doi:10.1186/cc3824 PubMedCrossRef

Lorente L, Jiménez A, Castedo J, Galván R, García C, Martín MM, Mora ML (2007) Internal jugular venous catheter-related bacteremia according to central and posterior accesses. Intensive Care Med 33(6):1071–1075. doi:10.1007/s00134-007-0647-6 PubMedCrossRef

Lorente L, Jiménez A, Galván R, García C, Castedo J, Martín MM, Mora ML (2007) Equivalence of posterior internal jugular and subclavian accesses in the incidence of central venous catheter related bacteremia. Intensive Care Med 33:2230–2231. doi:10.1007/s00134-007-0853-2 PubMedCrossRef

Lorente L, Jiménez A, García C, Galván R, Castedo J, Martín MM, Mora ML (2008) Catheter-related bacteremia from femoral and central internal jugular venous access. Eur J Clin Microbiol Infect Dis 27(9):867–781. doi:10.1007/s10096-008-0507-5 PubMedCrossRef

Lorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A (2008) The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Clin Infect Dis 47(9):1171–1175. doi:10.1086/592253 PubMedCrossRef

10.

Michel L, McMichan JC, Bachy JL (1979) Tracheostomy and indwelling central venous line: a hazardous combination? Intensive Care Med 5(2):83–86. doi:10.1007/BF01686052 PubMedCrossRef

11.

Dusan C, Bouchard P, Goudot B, Grozel JM, Perdrix JP, Banssillon V (1981) Bacteriologic study of indwelling central venous catheters. Factors influencing the risk of microbial colonization and sepsis. Anesth Analg (Paris) 38(7–8):347–350

12.

Garnacho-Montero J, Aldabó-Pallás T, Palomar-Martínez M, Vallés J, Almirante B, Garcés R, Grill F, Pujol M, Arenas-Giménez C, Mesalles E, Escoresca-Ortega A, de Cueto M, Ortiz-Leyba C (2008) Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: a multicenter study. Intensive Care Med 34(12):2185–2193. doi:10.1007/s00134-008-1204-7 PubMedCrossRef

13.

Pearson ML (1996) Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 24:262–277PubMedCrossRef

14.

O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51:1–29PubMed

15.

Lorente L, Huidobro MS, Martín MM, Jiménez A, Mora ML (2004) Accidental catheter removal in critically ill patients: a prospective and observational study. Crit Care 8(4):R229–R233. doi:10.1186/cc2874 PubMedCrossRef

16.

Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296:1305–1309PubMed

17.

Moro ML, Viganò EF, Cozzi Lepri A (1994) Risk factors for central venous catheter-related infections in surgical and intensive care units. The Central Venous Catheter-Related Infections Study Group. Infect Control Hosp Epidemiol 15(4 Pt 1):253–264PubMedCrossRef

18.

Mermel LA, McCormick RD, Springman SR, Maki DG (1991) The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 91(3B):197S–205S. doi:10.1016/0002-9343(91)90369-9 PubMedCrossRef

19.

Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggemann A, Napolitano LM, Edwards LP, O’Connell FM, Puyana JC, Doern GV (1998) Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 158(1):81–87. doi:10.1001/archinte.158.1.81 PubMedCrossRef

20.

Laura R, Degl’Innocenti M, Mocali M, Alberani F, Boschi S, Giraudi A, Arnaud MT, Zucchinali R, Paris MG, Dallara R, Thaler S, Perobelli G, Parfazi S, De Lazzer T, Peron G (2000) Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. The Italian Nurse Bone Marrow Transplant Group (GITMO). Haematologica 85:275–279PubMed

21.

Engervall P, Ringertz S, Hagman E, Skogman K, Björkholm M (1995) Change of central venous catheter dressings twice a week is superior to once a week in patients with haematological malignancies. J Hosp Infect 29:275–286. doi:10.1016/0195-6701(95)90274-0 PubMedCrossRef

22.

Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF (1985) The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 6(9):367–370PubMed

23.

Maki DG, Botticelli JT, LeRoy ML, Thielke TS (1987) Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective. JAMA 258(13):1777–1781. doi:10.1001/jama.258.13.1777 PubMedCrossRef

24.

León C, Alvarez-Lerma F, Ruiz-Santana S, González V, de la Torre MV, Sierra R, León M, Rodrigo JJ (2003) Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study. Crit Care Med 31(5):1318–1324. doi:10.1097/01.CCM.0000026327.58305.22 PubMedCrossRef

25.

Segura M, Alvarez-Lerma F, Tellado JM, Jiménez-Ferreres J, Oms L, Rello J, Baró T, Sánchez R, Morera A, Mariscal D, Marrugat J, Sitges-Serra A (1996) A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg 223(4):363–369. doi:10.1097/00000658-199604000-00004 PubMedCrossRef

26.

Halpin DP, O’Byrne P, McEntee G, Hennessy TP, Stephens RB (1991) Effect of a betadine connection shield on central venous catheter sepsis. Nutrition 7(1):33–34PubMed

27.

Niël-Weise BS, Daha TJ, van den Broek PJ (2006) Is there evidence for recommending needleless closed catheter access systems in guidelines? A systematic review of randomized controlled trials. J Hosp Infect 62(4):406–413. doi:10.1016/j.jhin.2005.10.005 PubMedCrossRef

Titel: Influence of tracheostomy on the incidence of central venous catheter-related bacteremia
Publikationsdatum: 01.09.2009
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 9/2009
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-009-0742-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Influence of tracheostomy on the incidence of central venous catheter-related bacteremia

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2009

Diversity and site-specificity of the oral microflora in the elderly

Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing

Detection of Salmonella enterica serovar Typhimurium with pUO-StVR2-like virulence-resistance hybrid plasmids in the United Kingdom

Streptococcus pneumoniae as a frequent cause of severe community-acquired pneumonia among children in Beijing

Two nosocomial norovirus outbreaks in the neonatal intensive and intermediate care unit

Evaluation of genotypic and phenotypic methods for differentiation of the members of the Anginosus group streptococci

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin